clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2026-104-2-84-94clinmed-1381Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПредсердная кардиомиопатияAtrial cardiomyopathyhttps://orcid.org/0009-0008-2019-9615ПужаловИ. А.PuzhalovI. A.

Пужалов Илья Алексеевич — слушатель ФГБВОУ ВО ВМедА им. С.М. Кирова Минобороны России.

Санкт-Петербург

Ilya A. Puzhalov — student.

St. Petersburg

ДемьяненкоА. В.DemyanenkoA. V.

Демьяненко Алексей Владимирович — д-р мед. наук, заместитель начальника ФКУ «ЦВКГ им. П.В. Мандрыка» по медицинской части

Москва

Alexey V. Demyanenko — Doctor of Medical Sciences Deputy Head of the Central Military Clinical Hospital named after P.V. Mandryk for the Medical part

Moscow

https://orcid.org/0000-0001-9389-6018ВаравинН. А.VaravinN. A.

Варавин Никита Алексеевич — канд. мед. наук, врач-кардиолог 1-й кафедры терапии усовершенствования врачей ФГБВОУ ВО ВМедАим. С.М. Кирова Минобороны России.

Nikita A. Varavin — Candidate of Medical Sciences, cardiologist.

St. Petersburg

nikvaravin91@mail.ruhttps://orcid.org/0009-0003-7761-0894СантаковА. А.SantakovA. A.

Сантаков Александр Андреевич — слушатель ФГБВОУ ВО ВМедА им. С.М. Кирова Минобороны России.

Alexander A. Santakov — student.

St. Petersburg

ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Минобороны РоссииРоссияMilitary Medical Academy named after S.M. Kirov of the Ministry of Defense of the RussiaRussian FederationФКУ «Центральный военный клинический госпиталь имени П.В. Мандрыка» Минобороны РоссииРоссияCenral Military Hospital named after P.V. Mandrykа of the Ministry of Defense of the RussiaRussian Federation20261904202610428494Copyright © Пужалов И.А., Демьяненко А.В., Варавин Н.А., Сантаков А.А., 20262026Пужалов И.А., Демьяненко А.В., Варавин Н.А., Сантаков А.А.Puzhalov I.A., Demyanenko A.V., Varavin N.A., Santakov A.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/1381

Понятие о предсердной кардиомиопатии — концепция, отражающая особое патофизиологическое состояние предсердий, лежащее в основе различных заболеваний. Накопление данных, свидетельствующих, что ремоделирование предсердий предшествует развитию фибрилляции предсердий, ишемического инсульта и сердечной недостаточности, позволило переосмыслить патофизиологическую роль предсердий в формировании сердечно-сосудистых заболеваний. В статье затронуты основные механизмы развития предсердной кардиомиопатии, их связь с морфологией и функцией предсердий. Анализ публикаций последних лет позволяет говорить о клинической значимости предсердной кардиомиопатии, о новых возможностях использования технологий визуализации и электрофизиологического исследования предсердий для оценки прогноза у пациентов. Поиск путей влияния на предсердную кардиомиопапию, возможно, позволит существенно улучшить исходы у пациентов с предсердными тахиаритмиями и сердечной недостаточностью.

Atrial cardiomyopathy is a concept reflecting a special pathophysiological condition of the atria underlying various diseases. The accumulation of data indicating that atrial remodeling precedes the development of atrial fibrillation, ischemic stroke, and heart failure has allowed the scientific community to begin rethinking the pathophysiological role of the atria in the formation of cardiovascular diseases. The article discusses the main mechanisms of atrial cardiomyopathy development and their relationship to atrial morphology and function. An analysis of recent publications suggests the clinical significance of atrial cardiomyopathy, new possibilities for using imaging technologies and electrophysiological examination of the atria to assess the prognosis in patients. The search for ways to influence atrial cardiomyopathy may significantly improve outcomes in patients with atrial tachyarrhythmias and heart failure.

атриопатиявоспалениеинсульткардиомиопатиякардиомиоцитлевое предсердиепатогенезремоделированиетромбоэмболияфибрилляция предсердийфиброзatriopathyinflammationstrokecardiomyopathycardiomyocyteleft atriumpathogenesisremodelingthromboembolismatrial fibrillationfibrosisИсследование не имело спонсорской поддержкиThe study had no sponsorshipReferencesPurwowiyoto S.L., Setianto B., Surya S.P. Atrial failure: what do we know about it? Acta Medica Indonesiana. 2022;54(1):131–137. https://www.actamedindones.org/index.php/ijim/article/view/1455/pdf (15.06.2025)Purwowiyoto S.L., Setianto B., Surya S.P. Atrial failure: what do we know about it? Acta Medica Indonesiana. 2022;54(1):131–137. https://www.actamedindones.org/index.php/ijim/article/view/1455/pdf (15.06.2025)Вайханская Т.Г., Курушко Т.В., Персидских Ю.А., Сивицкая Л.Н. Предсердная кардиомиопатия — новая концепция с давней историей. Российский кардиологический журнал. 2020;25(11):143–158. DOI: 10.15829/1560-4071-2020-3942Vaikhanskaya T.G., Kurushko T.V., Persianskikh Yu.A., Sivitskaya L.N. Atrial cardiomyopathy is a new concept with a long history. Russian Journal of Cardiology. 2020;25(11):143–158. (In Russ.). DOI: 10.15829/1560-4071-2020-3942Bisbal F., Baranchuk A., Braunwald E., Bayés de Luna A., BayésGenís A. Atrial failure as a clinical entity: JACC review topic of the week. Journal of the American College of Cardiology. 2020;75(2):222–232. DOI: 10.1016/j.jacc.2019.11.013Bisbal F., Baranchuk A., Braunwald E., Bayés de Luna A., BayésGenís A. Atrial failure as a clinical entity: JACC review topic of the week. Journal of the American College of Cardiology. 2020;75(2):222–232. DOI: 10.1016/j.jacc.2019.11.013Pathan F., D’Elia N., Nolan M.T., Marwick T.H., Negishi K. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. Journal of the American Society of Echocardiography. 2017;30(1):59–70. DOI: 10.1016/j.echo.2016.09.007Pathan F., D’Elia N., Nolan M.T., Marwick T.H., Negishi K. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. Journal of the American Society of Echocardiography. 2017;30(1):59–70. DOI: 10.1016/j.echo.2016.09.007Krittanawong C., Maitra N.S., Hassan Virk H.U., Farrell A., Hamzeh I., Arya B. et al. Normal ranges of right atrial strain: a systematic review and meta-analysis. JACC Cardiovascular Imaging. 2023;16(3):282–94. DOI: 10.1016/j.jcmg.2022.06.022Krittanawong C., Maitra N.S., Hassan Virk H.U., Farrell A., Hamzeh I., Arya B. et al. Normal ranges of right atrial strain: a systematic review and meta-analysis. JACC Cardiovascular Imaging. 2023;16(3):282–94. DOI: 10.1016/j.jcmg.2022.06.022Johnson L.S., Platonov P.G., Conen D., Kennbäck C., Jujic A., Healey J.S. et al. Markers of atrial myopathy in the general population: prevalence, predictors, and inter-relations. JACC Clinical Electrophysiology. 2023;9(11):2240–2249. DOI: 10.1016/j.jacep.2023.07.012Johnson L.S., Platonov P.G., Conen D., Kennbäck C., Jujic A., Healey J.S. et al. Markers of atrial myopathy in the general population: prevalence, predictors, and inter-relations. JACC Clinical Electrophysiology. 2023;9(11):2240–2249. DOI: 10.1016/j.jacep.2023.07.012Goette A., Kalman J.M., Aguinaga L., Akar J., Cabrera J.A., Chen S.A. et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. Journal of Arrhythmia. 2016;32(4):247–78. DOI: 10.1016/j.joa.2016.05.002Goette A., Kalman J.M., Aguinaga L., Akar J., Cabrera J.A., Chen S.A. et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. Journal of Arrhythmia. 2016;32(4):247–78. DOI: 10.1016/j.joa.2016.05.002Baman J.R., Cox J.L., McCarthy P.M., Kim D., Patel R.B., Passman R.S., Wilcox J.E. Atrial fibrillation and atrial cardiomyopathies. Journal of Cardiovascular Electrophysiology. 2021;32(10):2845– 2853. DOI: 10.1111/jce.15083Baman J.R., Cox J.L., McCarthy P.M., Kim D., Patel R.B., Passman R.S., Wilcox J.E. Atrial fibrillation and atrial cardiomyopathies. Journal of Cardiovascular Electrophysiology. 2021;32(10):2845– 2853. DOI: 10.1111/jce.15083Goette A., Lendeckel U. Atrial cardiomyopathy: pathophysiology and clinical consequences. Cells. 2021;10(10). DOI: 10.3390/cells10102605Goette A., Lendeckel U. Atrial cardiomyopathy: pathophysiology and clinical consequences. Cells. 2021;10(10). DOI: 10.3390/cells10102605Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104(2):174–180. DOI: 10.1161/01.CIR.104.2.174Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104(2):174–180. DOI: 10.1161/01.CIR.104.2.174Rennison J.H., Li L., Lin C.R., Lovano B.S., Castel L., Wass S.Y. et al. Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage. Pflügers Archiv — European Journal of Physiology. 2021;473(3):461–475. DOI: 10.1007/s00424-021-02514-5Rennison J.H., Li L., Lin C.R., Lovano B.S., Castel L., Wass S.Y. et al. Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage. Pflügers Archiv — European Journal of Physiology. 2021;473(3):461–475. DOI: 10.1007/s00424-021-02514-5Enríquez-Vázquez D., Quintanilla J.G., García-Escolano A., Couselo-Seijas M., Simón-Chica A., Lee P. et al. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value. Nature Communications. 2023;14(1):4613. DOI: 10.1038/s41467-023-40196-yEnríquez-Vázquez D., Quintanilla J.G., García-Escolano A., Couselo-Seijas M., Simón-Chica A., Lee P. et al. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value. Nature Communications. 2023;14(1):4613. DOI: 10.1038/s41467-023-40196-ySilva G.M., França-Falcão M.S., Calzerra N.T.M., Luz M.S., Gadelha D.D.A., Balarini C.M., Queiroz T.M. Role of renin-angiotensin system components in atherosclerosis: focus on Ang-II, ACE2, and Ang-1–7. Frontiers in Physiology. 2020;11:1067. DOI: 10.3389/fphys.2020.01067Silva G.M., França-Falcão M.S., Calzerra N.T.M., Luz M.S., Gadelha D.D.A., Balarini C.M., Queiroz T.M. Role of renin-angiotensin system components in atherosclerosis: focus on Ang-II, ACE2, and Ang-1–7. Frontiers in Physiology. 2020;11:1067. DOI: 10.3389/fphys.2020.01067Li C.Y., Zhang J.R., Hu W.N., Li S.N. Atrial fibrosis underlying atrial fibrillation (Review). International Journal of Molecular Medicine. 2021;47(3). DOI: 10.3892/ijmm.2020.4842Li C.Y., Zhang J.R., Hu W.N., Li S.N. Atrial fibrosis underlying atrial fibrillation (Review). International Journal of Molecular Medicine. 2021;47(3). DOI: 10.3892/ijmm.2020.4842Dilaveris P., Antoniou C.K., Manolakou P., Tsiamis E., Gatzoulis K., Tousoulis D. Biomarkers associated with atrial fibrosis and remodeling. Current Medicinal Chemistry. 2019;26(5):780–802. DOI: 10.21 74/0929867324666170918122502Dilaveris P., Antoniou C.K., Manolakou P., Tsiamis E., Gatzoulis K., Tousoulis D. Biomarkers associated with atrial fibrosis and remodeling. Current Medicinal Chemistry. 2019;26(5):780–802. DOI: 10.21 74/0929867324666170918122502Wang Y., Wang J., Shi L., Chen X., Li D., Cui C. et al. CIB2 Is a novel endogenous repressor of atrial remodeling. Circulation. 2023; 147(23):1758–1776. DOI: 10.1161/CIRCULATIONAHA.122.062660Wang Y., Wang J., Shi L., Chen X., Li D., Cui C. et al. CIB2 Is a novel endogenous repressor of atrial remodeling. Circulation. 2023; 147(23):1758–1776. DOI: 10.1161/CIRCULATIONAHA.122.062660Takahashi Y., Yamaguchi T., Otsubo T., Nakashima K., Shinzato K., Osako R. et al. Histological validation of atrial structural remodelling in patients with atrial fibrillation. European Heart Journal. 2023;44(35):3339–3353. DOI: 10.1093/eurheartj/ehad396Takahashi Y., Yamaguchi T., Otsubo T., Nakashima K., Shinzato K., Osako R. et al. Histological validation of atrial structural remodelling in patients with atrial fibrillation. European Heart Journal. 2023;44(35):3339–3353. DOI: 10.1093/eurheartj/ehad396Kirchhof P., Kahr P.C., Kaese S., Piccini I., Vokshi I., Scheld H.H. et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circulation Cardiovascular Genetics. 2011;4(2):123–133. DOI: 10.1161/CIRCGENETICS.110.958058Kirchhof P., Kahr P.C., Kaese S., Piccini I., Vokshi I., Scheld H.H. et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circulation Cardiovascular Genetics. 2011;4(2):123–133. DOI: 10.1161/CIRCGENETICS.110.958058Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (New York, NY). 2003;299(5604):251–254. DOI: 10.1126/science.1077771Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (New York, NY). 2003;299(5604):251–254. DOI: 10.1126/science.1077771Qiu D., Peng L., Ghista D.N., Wong K.K.L. Left atrial remodeling mechanisms associated with atrial fibrillation. Cardiovascular Engineering and Technology. 2021;12(3):361–372. DOI: 10.1007/s13239-021-00527-wQiu D., Peng L., Ghista D.N., Wong K.K.L. Left atrial remodeling mechanisms associated with atrial fibrillation. Cardiovascular Engineering and Technology. 2021;12(3):361–372. DOI: 10.1007/s13239-021-00527-wHuang J.K., Lee H.C. Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). International Journal of Molecular Sciences. 2022;23(8):4300. DOI: 10.3390/ijms23084300Huang J.K., Lee H.C. Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). International Journal of Molecular Sciences. 2022;23(8):4300. DOI: 10.3390/ijms23084300Venteclef N., Guglielmi V., Balse E., Gaborit B., Cotillard A., Atassi F. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. European Heart Journal. 2015;36(13):795–805. DOI: 10.1093/eurheartj/eht099Venteclef N., Guglielmi V., Balse E., Gaborit B., Cotillard A., Atassi F. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. European Heart Journal. 2015;36(13):795–805. DOI: 10.1093/eurheartj/eht099Tubeeckx M.R.L., Laga S., Jacobs C., Stroe M., Van Cruchten S., Goovaerts B. et al. Sterile pericarditis in aachener minipigs as a model for atrial myopathy and atrial fibrillation. Journal of Visualized Experiments: JoVE. 2021(175). DOI: 10.3791/63094Tubeeckx M.R.L., Laga S., Jacobs C., Stroe M., Van Cruchten S., Goovaerts B. et al. Sterile pericarditis in aachener minipigs as a model for atrial myopathy and atrial fibrillation. Journal of Visualized Experiments: JoVE. 2021(175). DOI: 10.3791/63094Liao C., Akazawa H., Tamagawa M., Ito K., Yasuda N., Kudo Y. et al. Cardiac mast cells cause atrial fibrillation through PDGF-A–mediated fibrosis in pressure-overloaded mouse hearts. Journal of Clinical Investigation. 2010;120(1):242–253. DOI: 10.1172/JCI39942Liao C., Akazawa H., Tamagawa M., Ito K., Yasuda N., Kudo Y. et al. Cardiac mast cells cause atrial fibrillation through PDGF-A–mediated fibrosis in pressure-overloaded mouse hearts. Journal of Clinical Investigation. 2010;120(1):242–253. DOI: 10.1172/JCI39942Chen Y., Surinkaew S., Naud P., Qi X.Y., Gillis M.A., Shi Y.F., Tardif J.C., Dobrev D., Nattel S. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate. Cardiovascular Research. 2017;113(3):310–320. DOI: 10.1093/cvr/cvx004Chen Y., Surinkaew S., Naud P., Qi X.Y., Gillis M.A., Shi Y.F., Tardif J.C., Dobrev D., Nattel S. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate. Cardiovascular Research. 2017;113(3):310–320. DOI: 10.1093/cvr/cvx004Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunological Reviews. 2009;230(1):160–71. DOI: 10.1111/j.1600-065X.2009.00794.xHenderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunological Reviews. 2009;230(1):160–71. DOI: 10.1111/j.1600-065X.2009.00794.xRegouski M., Galenko O., Doleac J., Olsen A.L., Jacobs V., Liechty D. et al. Spontaneous atrial fibrillation in transgenic goats with TGF (Transforming Growth Factor)-β1 induced atrial myopathy with endurance exercise. Circulation Arrhythmia and Electrophysiology. 2019;12(11):e007499. DOI: 10.1161/CIRCEP.119.007499Regouski M., Galenko O., Doleac J., Olsen A.L., Jacobs V., Liechty D. et al. Spontaneous atrial fibrillation in transgenic goats with TGF (Transforming Growth Factor)-β1 induced atrial myopathy with endurance exercise. Circulation Arrhythmia and Electrophysiology. 2019;12(11):e007499. DOI: 10.1161/CIRCEP.119.007499Olsen F.J., Bertelsen L., Vejlstrup N., Diederichsen S.Z., Bjerregaard C.L., Graff C. et al. Association between four-dimensional echocardiographic left atrial measures and left atrial fibrosis assessed by left atrial late gadolinium enhancement. European Heart Journal — Cardiovascular Imaging. 2022;24(1):152–161. DOI: 10.1093/ehjci/jeab275Olsen F.J., Bertelsen L., Vejlstrup N., Diederichsen S.Z., Bjerregaard C.L., Graff C. et al. Association between four-dimensional echocardiographic left atrial measures and left atrial fibrosis assessed by left atrial late gadolinium enhancement. European Heart Journal — Cardiovascular Imaging. 2022;24(1):152–161. DOI: 10.1093/ehjci/jeab275Litwin S.E., Komtebedde J., Hu M., Burkhoff D., Hasenfuß G., Borlaug B.A. et al. Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction. JACC Heart Failure. 2023;11(8Pt2):1103–1117. DOI: 10.1016/j.jchf.2023.01.030Litwin S.E., Komtebedde J., Hu M., Burkhoff D., Hasenfuß G., Borlaug B.A. et al. Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction. JACC Heart Failure. 2023;11(8Pt2):1103–1117. DOI: 10.1016/j.jchf.2023.01.030Marwick T.H., Chandrashekhar Y. Left atrial strain: part of the solution to taming the vicious twins. JACC Cardiovascular Imaging. 2020;13(10):2278–2279. DOI: 10.1016/j.jcmg.2020.09.001Marwick T.H., Chandrashekhar Y. Left atrial strain: part of the solution to taming the vicious twins. JACC Cardiovascular Imaging. 2020;13(10):2278–2279. DOI: 10.1016/j.jcmg.2020.09.001Dal Canto E., Remmelzwaal S., van Ballegooijen A.J., Handoko M.L., Heymans S., van Empel V. et al. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Failure Reviews. 2022;27(1):207–218. DOI: 10.1007/s10741-020-09985-1Dal Canto E., Remmelzwaal S., van Ballegooijen A.J., Handoko M.L., Heymans S., van Empel V. et al. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Failure Reviews. 2022;27(1):207–218. DOI: 10.1007/s10741-020-09985-1Sun P., Cen H., Chen S., Chen X., Jiang W., Zhu H. et al. Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers. BMC Cardiovascular Disorders. 2023;23(1):128. DOI: 10.1186/s12872-023-03127-9Sun P., Cen H., Chen S., Chen X., Jiang W., Zhu H. et al. Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers. BMC Cardiovascular Disorders. 2023;23(1):128. DOI: 10.1186/s12872-023-03127-9Ovchinnikov A.G., Potekhina A., Belyavskiy E., Gvozdeva A., Ageev F. Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome. Journal of Clinical Ultrasound: JCU. 2022;50(8):1073–1083. DOI: 10.1002/jcu.23318Ovchinnikov A.G., Potekhina A., Belyavskiy E., Gvozdeva A., Ageev F. Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome. Journal of Clinical Ultrasound: JCU. 2022;50(8):1073–1083. DOI: 10.1002/jcu.23318Jin X., Nauta J.F., Hung C.L., Ouwerkerk W., Teng T.H.K., Voors A.A., Lam C.S., van Melle J.P. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis. Heart Failure Reviews. 2022;27(5):1933–1955. DOI: 10.1007/s10741-02110204-8Jin X., Nauta J.F., Hung C.L., Ouwerkerk W., Teng T.H.K., Voors A.A., Lam C.S., van Melle J.P. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis. Heart Failure Reviews. 2022;27(5):1933–1955. DOI: 10.1007/s10741-02110204-8Tan E.S.J., Jin X., Oon Y.Y., Chan S.P., Gong L., Lunaria J.B. et al. Prognostic value of left atrial strain in aortic stenosis: a competing risk analysis. Journal of the American Society of Echocardiography. 2023;36(1):29-37. DOI: 10.1016/j.echo.2022.10.011Tan E.S.J., Jin X., Oon Y.Y., Chan S.P., Gong L., Lunaria J.B. et al. Prognostic value of left atrial strain in aortic stenosis: a competing risk analysis. Journal of the American Society of Echocardiography. 2023;36(1):29-37. DOI: 10.1016/j.echo.2022.10.011Molnár A.Á., Sánta A., Pásztor D.T., Merkely B. Atrial cardiomyopathy in valvular heart disease: from molecular biology to clinical perspectives. Cells. 2023;12(13):1796. DOI: 10.3390/cells12131796Molnár A.Á., Sánta A., Pásztor D.T., Merkely B. Atrial cardiomyopathy in valvular heart disease: from molecular biology to clinical perspectives. Cells. 2023;12(13):1796. DOI: 10.3390/cells12131796Vos J.L., Leiner T., van Dijk A.P.J., van der Zwaan H.B., Sieswerda G.T., Snijder R.J. et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. The International Journal of Cardiovascular Imaging. 2022;38(8):1699–1710. DOI: 10.1007/s10554-022-025556Vos J.L., Leiner T., van Dijk A.P.J., van der Zwaan H.B., Sieswerda G.T., Snijder R.J. et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. The International Journal of Cardiovascular Imaging. 2022;38(8):1699–1710. DOI: 10.1007/s10554-022-025556Ling L., Kistler P.M., Ellims A.H., Iles L.M., Lee G., Hughes G.L. et al. Diffuse ventricular fibrosis in atrial fibrillation. Journal of the American College of Cardiology. 2012;60(23):2402–2408. DOI: 10.1016/j.jacc.2012.07.065Ling L., Kistler P.M., Ellims A.H., Iles L.M., Lee G., Hughes G.L. et al. Diffuse ventricular fibrosis in atrial fibrillation. Journal of the American College of Cardiology. 2012;60(23):2402–2408. DOI: 10.1016/j.jacc.2012.07.065Bertelsen L., Diederichsen S.Z., Haugan K.J., Brandes A., Graff C., Krieger D. et al. Left atrial late gadolinium enhancement is associated with incident atrial fibrillation as detected by continuous monitoring with implantable loop recorders. JACC: Cardiovascular Imaging. 2020;13(8):1690–1700. DOI: 10.1016/j.jcmg.2020.03.024Bertelsen L., Diederichsen S.Z., Haugan K.J., Brandes A., Graff C., Krieger D. et al. Left atrial late gadolinium enhancement is associated with incident atrial fibrillation as detected by continuous monitoring with implantable loop recorders. JACC: Cardiovascular Imaging. 2020;13(8):1690–1700. DOI: 10.1016/j.jcmg.2020.03.024Park J.J., Park J.H., Hwang I.C., Park J.B., Cho G.Y., Marwick T.H. Left Atrial strain as a predictor of new-onset atrial fibrillation in patients with heart failure. JACC: Cardiovascular Imaging. 2020;13(10):2071–2081. DOI: 10.1016/j.jcmg.2020.04.031Park J.J., Park J.H., Hwang I.C., Park J.B., Cho G.Y., Marwick T.H. Left Atrial strain as a predictor of new-onset atrial fibrillation in patients with heart failure. JACC: Cardiovascular Imaging. 2020;13(10):2071–2081. DOI: 10.1016/j.jcmg.2020.04.031Gorcsan J. Can left atrial strain forecast future fibrillation? JACC: Cardiovascular Imaging. 2021;14(1):145–147. DOI: 10.1016/j.jcmg.2020.09.012Gorcsan J. Can left atrial strain forecast future fibrillation? JACC: Cardiovascular Imaging. 2021;14(1):145–147. DOI: 10.1016/j.jcmg.2020.09.012Anagnostopoulos I., Kousta M., Kossyvakis C., Paraskevaidis N.T., Schizas N., Vrachatis D., Deftereos S., Giannopoulos G. Atrial strain and occult atrial fibrillation in cryptogenic stroke patients: a systematic review and meta-analysis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2023;112(11):1600– 1609. DOI: 10.1007/s00392-023-02218-zAnagnostopoulos I., Kousta M., Kossyvakis C., Paraskevaidis N.T., Schizas N., Vrachatis D., Deftereos S., Giannopoulos G. Atrial strain and occult atrial fibrillation in cryptogenic stroke patients: a systematic review and meta-analysis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2023;112(11):1600– 1609. DOI: 10.1007/s00392-023-02218-zPavasini R., Fabbri G., Fiorio A., Campana R., Passarini G., Verardi F.M., Contoli M., Campo G. Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease. Echocardiography (Mount Kisco, NY). 2021;38(6):909–915. DOI: 10.1111/echo.15074Pavasini R., Fabbri G., Fiorio A., Campana R., Passarini G., Verardi F.M., Contoli M., Campo G. Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease. Echocardiography (Mount Kisco, NY). 2021;38(6):909–915. DOI: 10.1111/echo.15074Verbrugge F.H., Reddy Y.N.V., Attia Z.I., Friedman P.A., Noseworthy P.A., Lopez-Jimenez F., Kapa S., Borlaug B.A. Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography. Circulation Heart Failure. 2022;15(1):e008176. DOI: 10.1161/CIRCHEARTFAILURE.120.008176Verbrugge F.H., Reddy Y.N.V., Attia Z.I., Friedman P.A., Noseworthy P.A., Lopez-Jimenez F., Kapa S., Borlaug B.A. Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography. Circulation Heart Failure. 2022;15(1):e008176. DOI: 10.1161/CIRCHEARTFAILURE.120.008176Packer M. HFpEF Is the substrate for stroke in obesity and diabetes independent of atrial fibrillation. JACC Heart Failure. 2020;8(1):35–42. DOI: 10.1016/j.jchf.2019.09.002Packer M. HFpEF Is the substrate for stroke in obesity and diabetes independent of atrial fibrillation. JACC Heart Failure. 2020;8(1):35–42. DOI: 10.1016/j.jchf.2019.09.002Kamel H. Does Left atrial mechanical dysfunction contribute to a thrombogenic atrial myopathy? JACC Cardiovascular Imaging. 2019;12(12):2428–2430. DOI: 10.1016/j.jcmg.2019.02.008Kamel H. Does Left atrial mechanical dysfunction contribute to a thrombogenic atrial myopathy? JACC Cardiovascular Imaging. 2019;12(12):2428–2430. DOI: 10.1016/j.jcmg.2019.02.008Sanna T., Diener H.C., Passman R.S., Di Lazzaro V., Bernstein R.A., Morillo C.A. et al. Cryptogenic stroke and underlying atrial fibrillation. new England Journal of Medicine. 2014;370(26):2478–2486. DOI: 10.1056/NEJMoa1313600Sanna T., Diener H.C., Passman R.S., Di Lazzaro V., Bernstein R.A., Morillo C.A. et al. Cryptogenic stroke and underlying atrial fibrillation. new England Journal of Medicine. 2014;370(26):2478–2486. DOI: 10.1056/NEJMoa1313600Farhat K., Elkholey K., Asad Z.U.A, Stavrakis S. Atrial myopathy and ischemic stroke in heart failure with preserved ejection fraction. The American Journal of Cardiology. 2023;203:248–252. DOI: 10.1016/j.amjcard.2023.07.058Farhat K., Elkholey K., Asad Z.U.A, Stavrakis S. Atrial myopathy and ischemic stroke in heart failure with preserved ejection fraction. The American Journal of Cardiology. 2023;203:248–252. DOI: 10.1016/j.amjcard.2023.07.058Froehlich L., Meyre P., Aeschbacher S., Blum S., Djokic D., Kuehne M., Osswald S., Kaufmann B.A., Conen D. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(24):1884–1891. DOI: 10.1136/heartjnl-2019-315174Froehlich L., Meyre P., Aeschbacher S., Blum S., Djokic D., Kuehne M., Osswald S., Kaufmann B.A., Conen D. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(24):1884–1891. DOI: 10.1136/heartjnl-2019-315174Guo J., Wang D., Jia J., Zhang J., Peng F., Lu J., Zhao X., Liu Y. Atrial cardiomyopathy and incident ischemic stroke risk: a systematic review and meta-analysis. Journal of Neurology. 2023;270(7):3391– 3401. DOI: 10.1007/s00415-023-11693-3Guo J., Wang D., Jia J., Zhang J., Peng F., Lu J., Zhao X., Liu Y. Atrial cardiomyopathy and incident ischemic stroke risk: a systematic review and meta-analysis. Journal of Neurology. 2023;270(7):3391– 3401. DOI: 10.1007/s00415-023-11693-3Papapostolou S., Kearns J., Costello B.T., O’Brien J., Rudman M., Thompson M.C., Cloud G., Stub D., Taylor A.J. Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source. International Journal of Cardiology. 2023;389:131215. DOI: 10.1016/j.ijcard.2023.131215Papapostolou S., Kearns J., Costello B.T., O’Brien J., Rudman M., Thompson M.C., Cloud G., Stub D., Taylor A.J. Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source. International Journal of Cardiology. 2023;389:131215. DOI: 10.1016/j.ijcard.2023.131215Wang W., Zhang M.J., Inciardi R.M., Norby F.L., Johansen M.C., Parikh R. et al. Association of echocardiographic measures of left atrial function and size with incident dementia. JAMA. 2022;327(12):1138. DOI: 10.1001/jama.2022.2518Wang W., Zhang M.J., Inciardi R.M., Norby F.L., Johansen M.C., Parikh R. et al. Association of echocardiographic measures of left atrial function and size with incident dementia. JAMA. 2022;327(12):1138. DOI: 10.1001/jama.2022.2518Thiele K., Rau M., Grebe J., Korbinian Hartmann N.U., Altiok E., Böhm M. et al. Empagliflozin improves left atrial strain in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Circulation Cardiovascular Imaging. 2023;16(4):e015176. DOI: 10.1161/CIRCIMAGING.122.015176Thiele K., Rau M., Grebe J., Korbinian Hartmann N.U., Altiok E., Böhm M. et al. Empagliflozin improves left atrial strain in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Circulation Cardiovascular Imaging. 2023;16(4):e015176. DOI: 10.1161/CIRCIMAGING.122.015176Mouselimis D., Tsarouchas A.S., Pagourelias E.D., Bakogiannis C., Theofilogiannakos E.K., Loutradis C., Fragakis N., Vassilikos V.P., Papadopoulos C.E. Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. Hellenic Journal of Cardiology. 2020;61(3):154–164. DOI: 10.1016/j.hjc.2020.04.008Mouselimis D., Tsarouchas A.S., Pagourelias E.D., Bakogiannis C., Theofilogiannakos E.K., Loutradis C., Fragakis N., Vassilikos V.P., Papadopoulos C.E. Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. Hellenic Journal of Cardiology. 2020;61(3):154–164. DOI: 10.1016/j.hjc.2020.04.008Baalman S.W.E., van den Berg N.W.E., Neefs J., Berger W.R., Meulendijks E.R., de Bruin-Bon R.H.A.C.M. et al. Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT study. The International Journal of Cardiovascular Imaging. 2022;38(12):2615–2624. DOI: 10.1007/s10554-022-02645-5Baalman S.W.E., van den Berg N.W.E., Neefs J., Berger W.R., Meulendijks E.R., de Bruin-Bon R.H.A.C.M. et al. Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT study. The International Journal of Cardiovascular Imaging. 2022;38(12):2615–2624. DOI: 10.1007/s10554-022-02645-5Anagnostopoulos I., Kousta M., Kossyvakis C., Lakka E., Paraskevaidis N.T., Schizas N., Deftereos S., Giannopoulos G. The role of left atrial peak systolic strain in atrial fibrillation recurrence after catheter ablation. A systematic review and meta-analysis. Acta Cardiologica. 2022;77(6):536–544. DOI: 10.1080/00015385.2021.1965747Anagnostopoulos I., Kousta M., Kossyvakis C., Lakka E., Paraskevaidis N.T., Schizas N., Deftereos S., Giannopoulos G. The role of left atrial peak systolic strain in atrial fibrillation recurrence after catheter ablation. A systematic review and meta-analysis. Acta Cardiologica. 2022;77(6):536–544. DOI: 10.1080/00015385.2021.1965747Sperling J.S., Delurgio D.L., Svinarich J.T. Posterior left atrial epicardial adipose tissue: scope of the problem and impact of new technology. Current Opinion in Cardiology. 2022;37(1):54–61. DOI: 10.1097/HCO.0000000000000923Sperling J.S., Delurgio D.L., Svinarich J.T. Posterior left atrial epicardial adipose tissue: scope of the problem and impact of new technology. Current Opinion in Cardiology. 2022;37(1):54–61. DOI: 10.1097/HCO.0000000000000923Patel R.B., Reddy V.Y., Komtebedde J., Wegerich S.W., Sekaric J., Swarup V. et al. Atrial fibrillation burden and atrial shunt therapy in heart failure with preserved ejection fraction. JACC: Heart Failure. 2023;11(10):1351–1362. DOI: 10.1016/j.jchf.2023.05.024Patel R.B., Reddy V.Y., Komtebedde J., Wegerich S.W., Sekaric J., Swarup V. et al. Atrial fibrillation burden and atrial shunt therapy in heart failure with preserved ejection fraction. JACC: Heart Failure. 2023;11(10):1351–1362. DOI: 10.1016/j.jchf.2023.05.024Patel R.B., Shah S.J. Therapeutic targeting of left atrial myopathy in atrial fibrillation and heart failure with preserved ejection fraction. JAMA Cardiology. 2020;5(5):497. DOI: 10.1001/jamacardio.2020.0136Patel R.B., Shah S.J. Therapeutic targeting of left atrial myopathy in atrial fibrillation and heart failure with preserved ejection fraction. JAMA Cardiology. 2020;5(5):497. DOI: 10.1001/jamacardio.2020.0136Deal O., Rayner J., Stracquadanio A., Wijesurendra R.S., Neubauer S., Rider O., Spartera M. Effect of weight loss on early left atrial myopathy in people with obesity but no established cardiovascular disease. Journal of the American Heart Association. 2022;11(22). DOI: 10.1161/JAHA.122.026023Deal O., Rayner J., Stracquadanio A., Wijesurendra R.S., Neubauer S., Rider O., Spartera M. Effect of weight loss on early left atrial myopathy in people with obesity but no established cardiovascular disease. Journal of the American Heart Association. 2022;11(22). DOI: 10.1161/JAHA.122.026023

The authors declare that there are no conflicts of interest present.